Author:

  • All
  • --
  • ---
  • -2022
  • 2022-2
  • 2022-2-2-2
  • 2022-deltia-tipoy
  • 2022-deltia-tipoy-2-2
  • 2022-deltia-tipoy-2-2-2-2
  • 2023-deltia-typou
  • 2023-deltia-typou-2-2
  • 2024
  • 257-2
  • 257-2-2-2
  • 266-2
  • Announcements
  • Announcements 2025
  • Consolidated Financial Results
  • deltia-tipoy
  • deltia-tipoy-2-2
  • deltia-tipoy-2-2-2-2
  • Distribution of Divident
  • Events
  • FAQ
  • General Meetings and Corporate Actions
  • Insiders Transactions Disclosures
  • Invitations
  • invitations-2
  • Presentations
  • Press Kits
  • Press Releases
  • Regulated Information
  • Results 2024
  • Share Capital Increase
  • Uncategorized

Paiania, 28 March 2023 – Lavipharm S.A., according to the provisions of article 19 of the European Regulation No 596/2014 and the Regulation of the Athens Exchange, announces the appointment of Mr. Evangelos Paterakis as Chief Accountant replacing Mr. Panagiotis Pavlou, who is retiring.   ###...

Peania, 15 March 2023 - Lavipharm S.A. announces the key financial figures for 2022 and business developments in its activity: Lavipharm Flash Note FY2022 ...

Peania, 6 March 2023 - Lavipharm S.A, pursuant to articles 4.1.2 & 4.1.3.15.1 of the Athens Stock Exchange Rulebook, announces the Financial Calendar of 2023, as follows : FINANCIAL CALENDAR 2023...

Peania, 6 March 2023 - Lavipharm S.A, pursuant to articles 4.1.2 & 4.1.3.15.1 of the Athens Stock Exchange Rulebook, announces the Financial Calendar of 2023, as follows : FINANCIAL CALENDAR 2023...

Peania, 1 February 2023 – Lavipharm continues to expand its product portfolio in the Greek market by adding one more pharmaceutical product in the category of Urology. It is a fixed combination of dutasteride and tamsulosin addressing the symptoms of benign prostatic hyperplasia (BPH). Lavipharm’s...

Peania, 27 January 2023 – Lavipharm received an award from the National and Kapodistrian University of Athens (NKUA) in recognition of its many years of activity in the research, development and production of pharmaceutical products and its longstanding collaboration with the Department of Pharmacy of...

A new page in its presence on the stock exchange Peania, 22 December 2022 – As of Friday, 23 December 2022, the shares of Lavipharm S.A. will be traded again on the Main Market of the Athens Stock Exchange. Following the completion of the share capital increase,...

Peania, 22 December 2022 – As of Friday, 23 December 2022, the shares of Lavipharm S.A. will be traded again on the Main Market of the Athens Stock Exchange. Following the completion of the share capital increase, the Listings and Market Operation Committee of the Athens...